Developer docs
API playgroundTry for free, no card

Search company profiles

Panacea Medical Technologies

Full company profile

uuid0009pgs

Namestring
Panacea Medical Technologies
Legal namestring
Panacea Medical Technologies Pvt. Ltd.
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Panacea Medical Technologies Pvt. Ltd. is a privately held Indian MedTech manufacturer, founded in 1999 and headquartered in Malur, Kolar District, Karnataka, with a registered office in Bangalore. The company designs and produces radiotherapy and radiology capital equipment for cancer diagnosis and treatment, serving hospitals and cancer treatment centers primarily across South and Southeast Asia and East and West Africa. Its portfolio is organized into two segments: Radiation Oncology (Bhabhatron II, Bhabhatron 3i, Bhabhatron MLC, Siddharth II, Q-ri, IMAGIN, KLEO, and Impact patient positioning) and Radiology/Women's Health (KLEARAY digital radiography and the Lilac mammography family with tomosynthesis). The flagship Bhabhatron platform was co-developed with BARC (Bhabha Atomic Research Centre) and represents indigenous cobalt-based radiotherapy technology that competes on cost against linear accelerators in price-sensitive emerging markets.

Commercially, Panacea operates a direct enterprise sales model with quote-based pricing on capital equipment, supported by post-sale service contracts and a dedicated field service operation. The company has deployed 100+ radiotherapy machines that have treated more than 280,000 cancer patients globally, and Bhabhatron units have been donated through the Government of India to eight IAEA member countries. All major product lines hold CDSCO MD9 and AERB Type Approval for the Indian market, with several conforming to IEC international standards. The company is led by GVS Manyam as Managing Director and CTO and employs 51–100 people. Strategic positioning emphasizes affordability and access for under-served populations, ESG-aligned manufacturing (Panacea 2030 Climate Targets), and engagement with India's broader MedTech export agenda targeting a USD 30 billion sector by 2030. No revenue, recent funding, M&A, or executive changes beyond a 2013 New Enterprise Associates investor reference are disclosed.

Short descriptiontext

Panacea Medical Technologies is a privately held Indian MedTech manufacturer, founded in 1999, that designs and sells radiotherapy and radiology capital equipment — including the Bhabhatron cobalt platform co-developed with BARC and the Lilac mammography line — to hospitals and cancer centers across South/Southeast Asia and Africa.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersMalur, India
HQ citystring
Malur
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
radiotherapy equipment, radiology equipment, cancer treatment systems, medical imaging devices, radiation oncology
Industry2 codes
PRIMARYHLAHABAH
Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAHABAF
Mammography & Breast Imaging Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
NAICS code3 codes
  • Irradiation Apparatus Manufacturing334517
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
  • X-Ray Apparatus & Tubes & Related Irradiation Apparatus3844
Product category
Radiation Oncology and Radiology Medical Equipment
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Equipment Sales
TypeOne Time License
Description

Capital equipment sales of radiotherapy and radiology systems including Bhabhatron series, Siddharth II, Q-ri, Imagin, KLEARAY, and Lilac mammography systems. Sales model involves direct enterprise engagement with hospitals and cancer treatment centers.

panaceamedical.in
2Service and Support
TypeProfessional Services
Description

Post-sale technical support, installation, maintenance, and service contracts for installed base of 100+ radiotherapy machines. Dedicated service phone line (+91 735 375 3660) indicates ongoing service revenue stream.

panaceamedical.in
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Pricing details1 tier
1Capital equipment with quote-based pricing
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Pricing not publicly disclosed. Direct inquiry required for all product lines including radiotherapy systems and mammography equipment.

panaceamedical.in
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1Bhabhatron
Description

Cobalt-based radiotherapy treatment systems including Bhabhatron II, Bhabhatron 3i, and Bhabhatron MLC variants.

panaceamedical.in
+6 more records
Core offering1 text field

Panacea Medical Technologies manufactures radiotherapy and radiology capital equipment for cancer diagnosis and treatment. Its portfolio includes cobalt-based teletherapy units (Bhabhatron II, 3i, MLC), a linear accelerator (Siddharth II), an HDR brachytherapy afterloader (Q-ri), a CBCT-enabled radiotherapy simulator (IMAGIN), digital radiography systems (KLEARAY), and mammography systems (Lilac cassette, digital, and FFDM with tomosynthesis), sold to hospitals, cancer treatment centers, and women's health imaging facilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 100+ radiotherapy machines deployed across multiple regions
+2 more records
Product overview1 text field

Panacea Medical Technologies is a technology-centric company that manufactures radiotherapy and radiology equipment for cancer care. Their product portfolio consists of two main categories: Radiation Oncology products including Bhabhatron II (telecobalt therapy), Bhabhatron 3i (IGRT gamma therapy), Bhabhatron MLC (multileaf collimator), Siddharth II (MV beam therapy), Q-ri (HDR brachytherapy afterloader), IMAGIN (radiotherapy simulator with CBCT), and KLEO; and Radiology/Women's Health products including KLEARAY (digital radiography), Lilac FFDM with Tomosynthesis, Lilac Digital Mammography, and Lilac Cassette Mammography, plus supporting accessories like Impact (patient positioning) and View-Mam 3D (QA phantom). The company also offers quality assurance solutions for both radiation oncology and mammography.

Product and service13 records
1Bhabhatron II
CategoryRadiation Oncology - Telecobalt Therapy
Description

Telecobalt therapy unit for radiation treatment of cancer patients, featuring asymmetric collimation with independent jaws and trimmers for precise beam shaping up to 35x35 cm field size. Targets hospitals and cancer treatment centers and is CDSCO MD9 and AERB type approved with IEC standards compliance.

2Bhabhatron 3i
CategoryRadiation Oncology - IGRT Gamma Therapy
Description

Image-guided radiation therapy (IGRT) system on a cobalt platform enabling 3D-CRT and FiF-IMRT treatments, with ring gantry design, 6D robotic couch, and integrated imaging for precise, non-coplanar treatments at MLC speed of 2.5 cm/sec. Sold to hospitals and cancer centers requiring advanced cobalt-based IGRT.

3Bhabhatron MLC
CategoryRadiation Oncology - 3D Conformal Radiotherapy
Description

Multileaf collimator system combining cobalt platform robustness with precise 3D conformal dose delivery, featuring arc therapy and an integrated record-and-verify system. Targets radiation oncology departments needing state-of-the-art 3D conformal precise dose delivery on a cobalt platform; CDSCO MD9 and AERB type approved.

4Siddharth II
CategoryRadiation Oncology - Linear Accelerator
Description

MV Beam Therapy linear accelerator system for advanced radiation treatment delivery. Sold to hospitals and cancer centers needing linac-based external beam radiotherapy.

5Q-ri HDR Brachytherapy Afterloader
CategoryRadiation Oncology - HDR Brachytherapy
Description

24-channel HDR brachytherapy system supporting multi-catheter treatments with up to 100 dwell points per channel across 600 mm, automatic channel switching, emergency source retraction, and an integrated radiation detector for real-time source monitoring. Targets cancer centers performing precision internal radiation therapy.

6IMAGIN Radiotherapy Simulator
CategoryRadiation Oncology - Simulation and Verification
Description

Advanced flat panel radiotherapy simulator with CBCT capability for target delineation, treatment planning simulation, and patient position verification before treatment delivery, providing sub-millimeter precision compatible with any treatment machine. Targets radiotherapy departments; AERB type approved and CDSCO MD9 licensed.

7KLEO
CategoryRadiation Oncology
Description

Radiation oncology treatment system from Panacea's product portfolio for cancer treatment delivery in hospitals and oncology centers.

8KLEARAY Digital Radiography System
CategoryRadiology - Digital Radiography
Description

Wall-mounted motorized digital radiography system with advanced imaging, auto-stitching for full-spine/leg imaging, and seamless PACS/DICOM connectivity. Targets hospitals and diagnostic imaging facilities for general radiographic imaging.

9Lilac FFDM with Tomosynthesis
CategoryRadiology - Mammography / Women's Health
Description

Full-field digital mammography system with wide-angle 60-degree tomosynthesis, 29 projections, dose-equivalent 3D imaging, and Clear-View review workstation for accurate breast cancer diagnosis at every tissue depth. Targets women's health imaging centers and diagnostic facilities; CDSCO approved and AERB type approved.

10Lilac Digital Mammography
CategoryRadiology - Mammography / Women's Health
Description

State-of-the-art digital mammography platform designed for early breast cancer detection with high-quality imaging, intuitive workflow, and a flexible upgrade path to 3D tomosynthesis. Targets hospitals and women's health centers; CDSCO approved and AERB type approved.

11Lilac Cassette Mammography
CategoryRadiology - Mammography / Women's Health
Description

Cassette-based mammography unit with ergonomic design, gridless technology using air gap scatter removal, and variable compression speed for patient comfort. Targets diagnostic imaging facilities performing screening mammography; CDSCO approved and AERB type approved.

12Impact Patient Positioning System
CategoryRadiation Oncology - Patient Positioning Accessory
Description

Patient positioning system for accurate and reproducible patient setup during radiation therapy treatments, sold as a standalone accessory to radiotherapy departments.

13View-Mam 3D Mammography QA Phantom
CategoryRadiology - Quality Assurance
Description

Mammography tomosynthesis phantom used for acceptance testing, daily quality assurance, and routine quality checks with 3D image quality and DBT testing capabilities. Sold to mammography facilities for QA workflows.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Bhabhatron II, Panacea's flagship radiotherapy product, was developed in collaboration with BARC (Bhabha Atomic Research Centre), Mumbai. This government research institution partnership enabled development of India's indigenous cobalt-based radiotherapy technology.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Swedish-headquartered manufacturer of linacs (Versa HD, Elekta Unity MR-linac), Gamma Knife, and brachytherapy afterloaders (Flexitron). Overlaps directly with Panacea across cobalt/linac replacement and HDR brachytherapy, especially in LMIC markets.

TypeDirect peer
Description

Makes CyberKnife and TomoTherapy radiation therapy systems. Competes in advanced radiotherapy with Panacea's Bhabhatron 3i IGRT and Siddharth linac in emerging-market hospital tenders.

TypeBroad incumbent
Description

Major player in women's health imaging (MicroDose mammography) and diagnostic radiology. Competes with Panacea's Lilac and KLEARAY product lines for hospital imaging budgets.

TypeBroad incumbent
Description

Broad medical imaging and now radiotherapy portfolio (post-Varian acquisition). Overlaps with Panacea across mammography, simulation, and increasingly linear accelerators.

TypeBroad incumbent
Description

US-based leader in women's health imaging, including the 3Dimensions mammography system with tomosynthesis. Direct competitive overlap with Panacea's Lilac FFDM with Tomosynthesis in breast cancer screening tenders.

TypeEmerging player
Description

Makes compact proton therapy systems (MEVION S250). Adjacent emerging player in advanced radiation therapy, competing for next-generation radiotherapy capital in the same hospital segment as Panacea.

TypeBroad incumbent
Description

Global leader in linear accelerators, treatment planning software (Eclipse), and oncology information systems. Directly competes with Panacea in external beam radiotherapy tenders worldwide, with a far larger portfolio and service footprint.

TypeBroad incumbent
Description

Major incumbent across mammography (Senographe Pristina), digital radiography, and broader imaging. Competes with Panacea's Lilac mammography and KLEARAY DR systems in hospital procurement.

TypeEmerging player
Description

Developer of MRIdian, an MRI-guided radiation therapy system. Adjacent emerging competitor in image-guided radiotherapy, overlapping with Panacea's IGRT positioning on Bhabhatron 3i.

TypeDirect peer
Description

European manufacturer of HDR/PDR brachytherapy afterloaders and Co-60 / Ir-192 sources. Directly comparable to Panacea's Q-ri brachytherapy platform and Bhabhatron cobalt source business.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Panacea Medical Technologies

Radiation Oncology and Radiology Medical Equipmentpanaceamedical.in

Panacea Medical Technologies is a privately held Indian MedTech manufacturer, founded in 1999, that designs and sells radiotherapy and radiology capital equipment — including the Bhabhatron cobalt platform co-developed with BARC and the Lilac mammography line — to hospitals and cancer centers across South/Southeast Asia and Africa.

What Panacea Medical Technologies does

Panacea Medical Technologies Pvt. Ltd. is a privately held Indian MedTech manufacturer, founded in 1999 and headquartered in Malur, Kolar District, Karnataka, with a registered office in Bangalore. The company designs and produces radiotherapy and radiology capital equipment for cancer diagnosis and treatment, serving hospitals and cancer treatment centers primarily across South and Southeast Asia and East and West Africa. Its portfolio is organized into two segments: Radiation Oncology (Bhabhatron II, Bhabhatron 3i, Bhabhatron MLC, Siddharth II, Q-ri, IMAGIN, KLEO, and Impact patient positioning) and Radiology/Women's Health (KLEARAY digital radiography and the Lilac mammography family with tomosynthesis). The flagship Bhabhatron platform was co-developed with BARC (Bhabha Atomic Research Centre) and represents indigenous cobalt-based radiotherapy technology that competes on cost against linear accelerators in price-sensitive emerging markets.

Commercially, Panacea operates a direct enterprise sales model with quote-based pricing on capital equipment, supported by post-sale service contracts and a dedicated field service operation. The company has deployed 100+ radiotherapy machines that have treated more than 280,000 cancer patients globally, and Bhabhatron units have been donated through the Government of India to eight IAEA member countries. All major product lines hold CDSCO MD9 and AERB Type Approval for the Indian market, with several conforming to IEC international standards. The company is led by GVS Manyam as Managing Director and CTO and employs 51–100 people. Strategic positioning emphasizes affordability and access for under-served populations, ESG-aligned manufacturing (Panacea 2030 Climate Targets), and engagement with India's broader MedTech export agenda targeting a USD 30 billion sector by 2030. No revenue, recent funding, M&A, or executive changes beyond a 2013 New Enterprise Associates investor reference are disclosed.

Panacea Medical Technologies firmographics

Firmographics
Name
Panacea Medical Technologies
Legal name
Panacea Medical Technologies Pvt. Ltd.
Website
https://panaceamedical.in
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
251–500 employees
Short description
Panacea Medical Technologies is a privately held Indian MedTech manufacturer, founded in 1999, that designs and sells radiotherapy and radiology capital equipment — including the Bhabhatron cobalt platform co-developed with BARC and the Lilac mammography line — to hospitals and cancer centers across South/Southeast Asia and Africa.
Ownership category
akta.pro rank

Panacea Medical Technologies industry classification

Industry
Product category
Radiation Oncology and Radiology Medical Equipment
NAICS
Irradiation Apparatus Manufacturing (334517), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844)
akta.pro industry
PRIMARYHLAHABAH
Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAHABAF
Mammography & Breast Imaging Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

Keywords

  • Radiotherapy equipment
  • Radiology equipment
  • Cancer treatment systems
  • Medical imaging devices
  • Radiation oncology

Where Panacea Medical Technologies is headquartered

Location

Headquarters

HQ city
Malur
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Panacea Medical Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Medical Equipment Sales: Capital equipment sales of radiotherapy and radiology systems including Bhabhatron series, Siddharth II, Q-ri, Imagin, KLEARAY, and Lilac mammography systems. Sales model involves direct enterprise engagement with hospitals and cancer treatment centers.
  2. Service and Support: Post-sale technical support, installation, maintenance, and service contracts for installed base of 100+ radiotherapy machines. Dedicated service phone line (+91 735 375 3660) indicates ongoing service revenue stream.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractCapital equipment with quote-based pricing

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Panacea Medical Technologies product offering

Product offering

Core offering

Panacea Medical Technologies manufactures radiotherapy and radiology capital equipment for cancer diagnosis and treatment. Its portfolio includes cobalt-based teletherapy units (Bhabhatron II, 3i, MLC), a linear accelerator (Siddharth II), an HDR brachytherapy afterloader (Q-ri), a CBCT-enabled radiotherapy simulator (IMAGIN), digital radiography systems (KLEARAY), and mammography systems (Lilac cassette, digital, and FFDM with tomosynthesis), sold to hospitals, cancer treatment centers, and women's health imaging facilities.

Product overview

Panacea Medical Technologies is a technology-centric company that manufactures radiotherapy and radiology equipment for cancer care. Their product portfolio consists of two main categories: Radiation Oncology products including Bhabhatron II (telecobalt therapy), Bhabhatron 3i (IGRT gamma therapy), Bhabhatron MLC (multileaf collimator), Siddharth II (MV beam therapy), Q-ri (HDR brachytherapy afterloader), IMAGIN (radiotherapy simulator with CBCT), and KLEO; and Radiology/Women's Health products including KLEARAY (digital radiography), Lilac FFDM with Tomosynthesis, Lilac Digital Mammography, and Lilac Cassette Mammography, plus supporting accessories like Impact (patient positioning) and View-Mam 3D (QA phantom). The company also offers quality assurance solutions for both radiation oncology and mammography.

Differentiator

Problem solved

Functional benefit

Brands

  • Bhabhatron: Cobalt-based radiotherapy treatment systems including Bhabhatron II, Bhabhatron 3i, and Bhabhatron MLC variants.
  • Lilac
  • Siddharth
  • KLEARAY
  • Q-ri
  • Imagin
  • KLEO

Products and services

  • Bhabhatron II Telecobalt therapy unit for radiation treatment of cancer patients, featuring asymmetric collimation with independent jaws and trimmers for precise beam shaping up to 35x35 cm field size. Targets hospitals and cancer treatment centers and is CDSCO MD9 and AERB type approved with IEC standards compliance.
  • Bhabhatron 3i Image-guided radiation therapy (IGRT) system on a cobalt platform enabling 3D-CRT and FiF-IMRT treatments, with ring gantry design, 6D robotic couch, and integrated imaging for precise, non-coplanar treatments at MLC speed of 2.5 cm/sec. Sold to hospitals and cancer centers requiring advanced cobalt-based IGRT.
  • Bhabhatron MLC Multileaf collimator system combining cobalt platform robustness with precise 3D conformal dose delivery, featuring arc therapy and an integrated record-and-verify system. Targets radiation oncology departments needing state-of-the-art 3D conformal precise dose delivery on a cobalt platform; CDSCO MD9 and AERB type approved.
  • Siddharth II MV Beam Therapy linear accelerator system for advanced radiation treatment delivery. Sold to hospitals and cancer centers needing linac-based external beam radiotherapy.
  • Q-ri HDR Brachytherapy Afterloader 24-channel HDR brachytherapy system supporting multi-catheter treatments with up to 100 dwell points per channel across 600 mm, automatic channel switching, emergency source retraction, and an integrated radiation detector for real-time source monitoring. Targets cancer centers performing precision internal radiation therapy.
  • IMAGIN Radiotherapy Simulator Advanced flat panel radiotherapy simulator with CBCT capability for target delineation, treatment planning simulation, and patient position verification before treatment delivery, providing sub-millimeter precision compatible with any treatment machine. Targets radiotherapy departments; AERB type approved and CDSCO MD9 licensed.
  • KLEO Radiation oncology treatment system from Panacea's product portfolio for cancer treatment delivery in hospitals and oncology centers.
  • KLEARAY Digital Radiography System Wall-mounted motorized digital radiography system with advanced imaging, auto-stitching for full-spine/leg imaging, and seamless PACS/DICOM connectivity. Targets hospitals and diagnostic imaging facilities for general radiographic imaging.
  • Lilac FFDM with Tomosynthesis Full-field digital mammography system with wide-angle 60-degree tomosynthesis, 29 projections, dose-equivalent 3D imaging, and Clear-View review workstation for accurate breast cancer diagnosis at every tissue depth. Targets women's health imaging centers and diagnostic facilities; CDSCO approved and AERB type approved.
  • Lilac Digital Mammography State-of-the-art digital mammography platform designed for early breast cancer detection with high-quality imaging, intuitive workflow, and a flexible upgrade path to 3D tomosynthesis. Targets hospitals and women's health centers; CDSCO approved and AERB type approved.
  • Lilac Cassette Mammography Cassette-based mammography unit with ergonomic design, gridless technology using air gap scatter removal, and variable compression speed for patient comfort. Targets diagnostic imaging facilities performing screening mammography; CDSCO approved and AERB type approved.
  • Impact Patient Positioning System Patient positioning system for accurate and reproducible patient setup during radiation therapy treatments, sold as a standalone accessory to radiotherapy departments.
  • View-Mam 3D Mammography QA Phantom Mammography tomosynthesis phantom used for acceptance testing, daily quality assurance, and routine quality checks with 3D image quality and DBT testing capabilities. Sold to mammography facilities for QA workflows.

Quantifiable outcome

  • 100+ radiotherapy machines deployed across multiple regions
  • +2 more outcomes

Companies that use Panacea Medical Technologies

Customer profile

Named customers4 records

Segments2 records

Ideal customer profiles3 records

Panacea Medical Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Panacea Medical Technologies partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • BARC (Bhabha Atomic Research Centre)coreStrategic or Co-development PartnerBhabhatron II, Panacea's flagship radiotherapy product, was developed in collaboration with BARC (Bhabha Atomic Research Centre), Mumbai. This government research institution partnership enabled development of India's indigenous cobalt-based radiotherapy technology.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Panacea Medical Technologies competitors and assessment

Company assessment

Direct peers

  • Elekta: Swedish-headquartered manufacturer of linacs (Versa HD, Elekta Unity MR-linac), Gamma Knife, and brachytherapy afterloaders (Flexitron). Overlaps directly with Panacea across cobalt/linac replacement and HDR brachytherapy, especially in LMIC markets.
  • Accuray: Makes CyberKnife and TomoTherapy radiation therapy systems. Competes in advanced radiotherapy with Panacea's Bhabhatron 3i IGRT and Siddharth linac in emerging-market hospital tenders.
  • Eckert & Ziegler BEBIG: European manufacturer of HDR/PDR brachytherapy afterloaders and Co-60 / Ir-192 sources. Directly comparable to Panacea's Q-ri brachytherapy platform and Bhabhatron cobalt source business.

Broad incumbents

  • Philips Healthcare: Major player in women's health imaging (MicroDose mammography) and diagnostic radiology. Competes with Panacea's Lilac and KLEARAY product lines for hospital imaging budgets.
  • Siemens Healthineers: Broad medical imaging and now radiotherapy portfolio (post-Varian acquisition). Overlaps with Panacea across mammography, simulation, and increasingly linear accelerators.
  • Hologic: US-based leader in women's health imaging, including the 3Dimensions mammography system with tomosynthesis. Direct competitive overlap with Panacea's Lilac FFDM with Tomosynthesis in breast cancer screening tenders.
  • Varian Medical Systems (Siemens Healthineers): Global leader in linear accelerators, treatment planning software (Eclipse), and oncology information systems. Directly competes with Panacea in external beam radiotherapy tenders worldwide, with a far larger portfolio and service footprint.
  • GE HealthCare: Major incumbent across mammography (Senographe Pristina), digital radiography, and broader imaging. Competes with Panacea's Lilac mammography and KLEARAY DR systems in hospital procurement.

Emerging players

  • Mevion Medical Systems: Makes compact proton therapy systems (MEVION S250). Adjacent emerging player in advanced radiation therapy, competing for next-generation radiotherapy capital in the same hospital segment as Panacea.
  • ViewRay: Developer of MRIdian, an MRI-guided radiation therapy system. Adjacent emerging competitor in image-guided radiotherapy, overlapping with Panacea's IGRT positioning on Bhabhatron 3i.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Panacea Medical Technologies social profiles

Digital presence

Panacea Medical Technologies compliance and trust

Trust signal

Compliance9 records

Panacea Medical Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Panacea Medical Technologies leadership team

Management profile

Number of profiles

Profiles1 record

Panacea Medical Technologies funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Panacea Medical Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Panacea Medical Technologies

What does Panacea Medical Technologies do?

Panacea Medical Technologies manufactures radiotherapy and radiology capital equipment for cancer diagnosis and treatment. Its portfolio includes cobalt-based teletherapy units (Bhabhatron II, 3i, MLC), a linear accelerator (Siddharth II), an HDR brachytherapy afterloader (Q-ri), a CBCT-enabled radiotherapy simulator (IMAGIN), digital radiography systems (KLEARAY), and mammography systems (Lilac cassette, digital, and FFDM with tomosynthesis), sold to hospitals, cancer treatment centers, and women's health imaging facilities.

Is Panacea Medical Technologies a public or private company?

Panacea Medical Technologies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Panacea Medical Technologies founded?

Panacea Medical Technologies was founded in 1999. It employs 251 to 500 people.

Where is Panacea Medical Technologies based?

Panacea Medical Technologies is headquartered in Malur, India, in the Asia region.

How does Panacea Medical Technologies make money?

Two revenue lines are on record. Medical Equipment Sales are the primary driver. The others are service and Support.

Who are Panacea Medical Technologies's main competitors?

Direct peers on record are Elekta, Accuray and Eckert & Ziegler BEBIG. Broad incumbents are Philips Healthcare, Siemens Healthineers, Hologic, Varian Medical Systems (Siemens Healthineers) and GE HealthCare. Emerging players are Mevion Medical Systems and ViewRay.

Does Panacea Medical Technologies have an API?

No public API is recorded for Panacea Medical Technologies.

What industry is Panacea Medical Technologies in?

Panacea Medical Technologies's product category is Radiation Oncology and Radiology Medical Equipment. Its primary akta.pro industry code is HLAHABAH, Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim), with a secondary code of HLAHABAF, Mammography & Breast Imaging Systems. Its NAICS code is 334517 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BignewsnetworkGujarat to Global: Empowering MedTech Ecosystem to be held in Gandhinagar on June 23Gujarat Rajya Institution for Transformation (GRIT) and Export Promotion Council for Medical Devices (EPCMD India) will jointly host the 'Gujarat to Global: Empowering the MedTech Ecosystem' conference in Gandhinagar on June 23 to advance Gujarat's medical device sector. With the Nagalpar Medical Device Park near Rajkot now operational, manufacturers are increasingly shifting from basic assembly to advanced, export-oriented production aligned with India's USD 30 Billion MedTech Vision for 2030. The event will bring together policymakers, regulators, and industry leaders from companies including SMT, BPL, Meril Life Sciences, Philips India, Wipro GE Healthcare, and Panacea Medical Technologies to discuss regulatory pathways, quality standards, and export competitiveness.Ani NewsGujarat to Global: Empowering MedTech Ecosystem to be held in Gandhinagar on June 23Gujarat Rajya Institution for Transformation (GRIT) and Export Promotion Council for Medical Devices (EPCMD India) will jointly host a MedTech sector conference titled 'Gujarat to Global: Empowering the MedTech Ecosystem' on June 23 in Gandhinagar. The conference aims to bridge local manufacturing capabilities with global market opportunities, coinciding with the Nagalpar Medical Device Park near Rajkot becoming operational and manufacturers shifting toward advanced, export-oriented production. The event will bring together government officials from the Department of Pharmaceuticals, Department of Commerce, and CDSCO alongside industry leaders from companies including SMT, BPL, Meril Life Sciences, Philips India, Wipro GE Healthcare, and Panacea Medical Technologies to discuss policy frameworks and regulatory pathways for global market access.PR NewswireGrowing Awareness of the Benefits of Radiotherapy and the Increasing Use of Particle Therapy for Cancer Treatment is expected to Drive the Global Radiation Therapy Market | UnivDatos Market InsightsAccording to a new market research report by UnivDatos Market Insights, the global Radiation Therapy Market was valued at over USD 6 billion in 2020 and is projected to grow at a CAGR of around 6% from 2021-2027, driven by increasing adoption of radiotherapy procedures and particle therapy for cancer treatment. The report segments the market by type, technology, application, and end-user, with North America dominating due to well-established healthcare infrastructure. Key players profiled include GE Healthcare, Siemens Healthineers, Varian Medical Systems, Ion Beam Application, Accuray Incorporated, Panacea Medical Technologies, ZEISS Group, IntraOp Medical, ViewRay, and Eckert & Ziegler.The Economic TimesEntrepreneurs with social mission: Four Indian startups that are fighting cancerFour Indian startups are developing cancer treatments: Panacea Medical Technologies makes radiation therapy machines, Navya Network offers online oncology consultations, UE Lifesciences created a breast cancer screening device, and Perfint builds robotic tumour treatment devices. Panacea aims for 35% market share and a 2021 IPO, while Navya plans to expand beyond breast cancer.